Topics

High-grade gliomas | Treatment | Clinical trials | SM-1 (Pro-apoptotic drug)

Home > Publications > Topics > High-grade gliomas > Treatment > Clinical trials > SM-1

Huang M, Kang Z, Li S, Zhang B, Xiao Y, Li S, Li W.
Phase I clinical trial of a novel procaspase-3 activator SM-1 with temozolomide in recurrent high-grade gliomas.
Neoplasia. 2025 Feb 18;61:101141. doi: 10.1016/j.neo.2025.101141. PMID: 39970841. Interventional study. ˍ